Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(2)
Bioquímica(1)
Fisiología y materias afines(1)
Origen
scopus(3)
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusEag1 gene and protein expression in human retinoblastoma tumors and its regulation by pRb in HeLa cells
ArticleAbstract: Retinoblastoma is the most common pediatric intraocular malignant tumor. Unfortunately, low cure ratPalabras claves:Astemizole, Eag1 channels, KCNH1, Kv10.1, Potassium channels, Retinoblastoma, tumor suppressorAutores:Avalos-fuentes A., Cabrera-muñoz M.d.L., Castro-Magdonel B.E., Chávez-lópez M.d.G., Escobar Y., Garrido E., Hernández-gallegos E., Javier Camacho, Ortiz C.S., Ponce-castañeda M.V., Sanchez-Ramos J., Vera E., Zúñiga-García V.Fuentes:scopusThe combination astemizole–gefitinib as a potential therapy for human lung cancer
ArticleAbstract: Lung cancer is a major cause of cancer mortality. Thus, novel therapies are urgently needed. RepositPalabras claves:Astemizole, Gefitinib, lung cancer, Potassium channelsAutores:Carmen Alexandra Chasiquiza-Anchatuña, Chávez-lópez M.d.G., Garrido E., Hernández-gallegos E., Javier Camacho, Marco Viteri-Yánez, Sanchez-Ramos J., Vera E., Zúñiga-García V.Fuentes:scopus